Clinical Trial Update: A Study to Evaluate Effects of KN056 in Healthy Participants [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study evaluating KN056 in healthy participants; Type 2 diabetes mellitus is listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• KN056

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED